The study showed that CDKN1A upregulation induced by miR-93-5p CDKN1A could block the TGF-β and thus increase the therapeutic effects of chemotherapy on small cell lung cancer cells [29]. This evidence concerns the gene CDKN1A and small cell lung carcinoma.